These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38874878)

  • 21. Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review.
    Castaño A; Bokhari S; Brannagan TH; Wynn J; Maurer MS
    Amyloid; 2012 Mar; 19(1):41-6. PubMed ID: 22149423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardization of
    Bokhari S; Morgenstern R; Weinberg R; Kinkhabwala M; Panagiotou D; Castano A; DeLuca A; Kontak A; Jin Z; Maurer MS
    J Nucl Cardiol; 2018 Feb; 25(1):181-190. PubMed ID: 27580616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
    González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Flaherty KR; Morgenstern R; Pozniakoff T; DeLuca A; Castano A; Maurer MS; Bokhari S
    J Nucl Cardiol; 2020 Apr; 27(2):371-380. PubMed ID: 31463816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial scanning with technetium pyrophosphate (
    Castaño A; DeLuca A; Weinberg R; Pozniakoff T; Blaner WS; Pirmohamed A; Bettencourt B; Gollob J; Karsten V; Vest JA; Chiuzan C; Maurer MS; Bokhari S
    J Nucl Cardiol; 2016 Dec; 23(6):1355-1363. PubMed ID: 26453570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 1-h with 3-h planar
    Saitou T; Aikawa T; Manabe O; Nagase A; Kudo T; Oyama-Manabe N
    Ann Nucl Med; 2023 Feb; 37(2):99-107. PubMed ID: 36352186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and prognostic value of Technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis.
    Miller RJH; Cadet S; Mah D; Pournazari P; Chan D; Fine NM; Berman DS; Slomka PJ
    J Nucl Cardiol; 2021 Oct; 28(5):1835-1845. PubMed ID: 33689152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac MRI T1 and T2 Mapping as a Quantitative Imaging Biomarker in Transthyretin Amyloid Cardiomyopathy.
    Yamaguchi S; Oda S; Kidoh M; Hayashi H; Takashio S; Usuku H; Nagayama Y; Nakaura T; Tsujita K; Hirai T; Aoki T
    Acad Radiol; 2024 Feb; 31(2):514-522. PubMed ID: 37775448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tc-99m-pyrophosphate scintigraphy for the diagnosis of ATTR cardiac amyloidosis: Comparison of quantitative and semi-quantitative approaches.
    Régis C; Harel F; Martineau P; Grégoire J; Abikhzer G; Juneau D; Pelletier-Galarneau M
    J Nucl Cardiol; 2020 Oct; 27(5):1808-1815. PubMed ID: 32476105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the Kumamoto criteria for prediction of
    Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
    J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
    Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T
    Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing cardiac amyloidosis assessment: utility of 1-h and 3-h
    Imakhanova A; Ideguchi R; Kawano H; Maemura K; Kudo T
    Eur J Med Res; 2024 Jan; 29(1):32. PubMed ID: 38184638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transthyretin amyloid cardiomyopathy among patients with heart failure and preserved ejection fraction: the AMY score.
    Gioia G; Schrutka L; Jozwiak-Nozdrzykowska J; Kresoja KP; Gunold H; Klingel K; Thiele H; Bonderman D; Lurz P; Rommel KP
    ESC Heart Fail; 2024 Aug; 11(4):2172-2181. PubMed ID: 38613409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.
    Cuddy SA; Datar Y; Ovsak G; Saith S; Murphy SP; Bay CP; Haddad M; Lilleness B; Muralidhar V; Pipilas A; Vuong J; Guardino E; Maurer MS; Ruberg FL; Falk RH; Dorbala S
    Circ Cardiovasc Imaging; 2022 Nov; 15(11):e014645. PubMed ID: 36378779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review.
    Ungericht M; Wanschitz J; Kroiss AS; Röcken C; Schuetz T; Messner M; Zaruba MM; Loescher WN; Poelzl G
    J Nucl Cardiol; 2023 Aug; 30(4):1420-1426. PubMed ID: 35581484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.
    Nagai T; Horinouchi H; Hashimoto K; Ichiji T; Yoshioka K; Hashimoto J; Ikari Y
    Echocardiography; 2023 Jul; 40(7):634-641. PubMed ID: 37243310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis.
    Tamarappoo B; Otaki Y; Manabe O; Hyun M; Cantu S; Arnson Y; Gransar H; Hayes SW; Friedman JD; Thomson L; Slomka P; Dey D; Vescio R; Patel J; Berman DS
    J Nucl Cardiol; 2020 Feb; 27(1):28-37. PubMed ID: 31172386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case of Biopsy-Proven Wild-Type ATTR Cardiac Amyloidosis With Abnormal CMR and Negative
    Yabut J; Nadig V; Arora S; Hirsch D; Duvall WL
    Circ Cardiovasc Imaging; 2024 Jan; 17(1):e015734. PubMed ID: 38146653
    [No Abstract]   [Full Text] [Related]  

  • 39. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Castaño A; Narotsky DL; Hamid N; Khalique OK; Morgenstern R; DeLuca A; Rubin J; Chiuzan C; Nazif T; Vahl T; George I; Kodali S; Leon MB; Hahn R; Bokhari S; Maurer MS
    Eur Heart J; 2017 Oct; 38(38):2879-2887. PubMed ID: 29019612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
    Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.